Biosimilars Development In EU Could Get Easier; EC Mulls Accepting Outside Data

Industry applauds a suggestion by a senior healthcare representative that the European Commission could re-examine the overarching guideline on biosimilars to promote global development, but growth ultimately will be determined by greater worldwide harmonization.